 Back to Conference page
|
UICC World Cancer Congress 2006Bridging the Gap: Transforming Knowledge into ActionJuly 8-12, 2006, Washington, DC, USA |
| Tuesday, 11 July 2006: 12:00 PM-1:30 PM | |||
| Exhibit Hall D (Convention Center) | |||
| Cancer Research, Detection and Treatment | |||
| 167-1 | Mutations in P53 and K-Ras and Microsatellite Instability Status Define Distinct Disease Subtypes in Colorectal Cancer Patients from Iran Faraz Bishehsari (Iran) | ||
| 167-2 | Galectin-3 Inhibits Trail-Induced Apoptosis by Activating Akt in Human Bladder Carcinoma Cells Natsuo Oka (Japan), Tomoharu Fukumori (Japan), Hiro-omi Kanayama (Japan), Avraham Raz (USA) | ||
| 167-3 | From Molecular Genetics to Family Care Maggie Watson (United Kingdom), Claire Foster (United Kingdom), Nina Hallowell (United Kingdom), Diana Eccles (United Kingdom), Rosalind Eeles, Gareth Evans (United Kingdom) | ||
| 167-4 | Alteration of Promoter Methylation of Selected Tumor Suppressor Genes by Adenosine Analogs in Combination with Natural Compounds in Mcf-7 Cells Krystyna Fabianowska-Majewska (Poland), Barbara Krawczyk (Poland) | ||
| 167-5 | Understanding the Prognosis of the Oncogenic Mutations of Survivin precursor- and p53- Genes in the Development of Benign Cancer, in Planning Treatment Formulations Pharm VINCENT OGHENEKEVBE. OLUGHOR (Nigeria), DAMIAN ONYEMA IHEDIOHA (Nigeria) | ||
| 167-6 | Alteration of Rpl14 in Squamous Cell Carcinomas and Preneoplastic Lesions Xiao-Ping Huang (China) | ||
| 167-7 | Understanding the Molecular Basis of Malignancy of a Benign Cancer in Planning Treatment Formulations Pharm VINCENT OGHENEKEVBE. OLUGHOR (Nigeria), DAMIAN ONYEMA IHEDIOHA (Nigeria) | ||
| 167-8 | The Role of Natural Death Ligands in Cancer Chemotherapy Natalia N. Petenko (Russia) | ||
| 167-9 | The Significance of Static DNA Cytometry as a Diagnostic Aid in Effusion Cytology /Aneuploidy for the Detection & Differentiation of the Mesothelioma Tumors of the Serous Membranes Ishaq M (Pakistan) | ||
| 167-10 | Systemic Immunobiological Characterization of Brain Tumor Cells Bela Bodey (USA), Stuart E. Siegel (USA), Hans E. Kaiser | ||
| 167-11 | TGF-ß1 and IL-10 Inhibit T-Lymphocytes Proliferation and CD3-ζ Expression in Cervical Cancer Cinthya Estefhany Díaz-Benítez Jr. (Mexico), Jaqueline Atala Flores-Sosa (Mexico), Karla Navarro-Fuentes (Mexico), Yanet Juárez-Díaz (Mexico), Guillermina López-Estrada (Mexico), Patricia Alonso de Ruíz (Mexico), Edgar Román-Basaure (Mexico), Jesús Martínez-Barnetche (Mexico), Alfredo Lagunas-Martínez (Mexico), Victor Hugo Bermúdez-Morales (Mexico), José Moreno-Rodríguez (Mexico), Rogelio Hernández-Pando (Mexico), Yvonne Rosenstein-Asoulay (Mexico), Juan Manuel Alcocer (Mexico), Vicente Madrid-Marina (Mexico) | ||
| 167-12 | Viability of a Pediatric Hematopoietic Progenitor Transplantation Unit in a Developing Country. the First Report of Hospital Civil in Guadalajara, Mexico O. González-Ramella (Mexico) | ||
| 167-13 | Molecular Pathways in the Chemosensitization of Cisplatin by Quercetin in Human Head and Neck Cancer HIMANI SHARMA (India), NEETA SINGH (India) | ||
| 167-14 | Vascular Endothelial Growth Factor in Bronchoalveolar Lavage Fluid in Sulfur Mustard Exposed Lung Patients Ali KARAMI (Iran), Mostafa Ghanei (Iran), Mehdi Eshraghi (Iran) | ||
| 167-15 | Tobacco Smoking and Gstp1 Polymorphism in Bladder Carcinoma Vladimir Fedotov (Ukraine) | ||
| 167-16 | Inhibition of Telomerase Activity in Cancer Cells Using Short Hairpin RNA Expression Vectors Shi-Ming Chen Sr. (China), Ze-Zhang Tao (China), Xu-Hong Zhou (China), Hong-Gang Duan (China), Jie Cheng (China) | ||
| 167-17 | Pathology-Based Frequency Study of Cancer: an Alternative Strategy for Cancer Registration in Remote, Low-Resource Settings Sani A. Malami (Nigeria), Bawa A Abimiku (Nigeria), Umar H Pindiga (Nigeria) | ||
| 167-18 | The Change of Gene Expression Profiles in Breast Cancer Cell Lines Treated by Anticancer Drugs Hong Liu (China), Ruifang Niu (China), Yurong Shi (China), Baocun Sun (China), Xishan Hao (China) | ||
| 167-19 | Detection of a Taregt for New Anticancer Treatments in Normal and Abnormal Prostatic Tissues from Black Men E. Oluwabunmi Olapade-Olaopa (Nigeria) | ||
| 167-20 | Investigations on Cytotoxic and Antiproliferative Effects of Newly Synthesized Complexes of Zn(II), Cu(I, II), Co(II), Ni(II) and Fe(II, III) with Mannich Type Ligands on Tumor Cell Lines Radostina I. Alexandrova (Bulgaria), Elena B. Nikolova (Bulgaria), Elena Maria Mosoarca (Romania), Ramona Tudose (Romania), Otilia Costisor (Romania) | ||
| 167-21 | Developing Oncology Outreach Services in Western Kenya Pamela Were (Kenya) | ||
| 167-22 | The Impact of Direct Current on Walker 256 Carcinosarcoma (W256) Growth Aliaksandr Zhukavets (Belarus) | ||
| 167-23 | Suppression of Tumor Growth by a Protease Inhibitor, Camostat Mesilate: an Experimental Study Nobuo Murata (Japan), Tsuyoshi Suzuki (Japan), Tomonori Oosawa (Japan), Hideyuki Ishida (Japan) | ||
| 167-24 | Polymorphism of Il-1 a, Il-1 B and Il-10 in Patients with Advanced Ovarian Cancer (Oc) Elena Ioana Braicu (Romania), Ionela Cristina Pirvulescu (Romania), Alexandru Mustea (Germany), Dominique Könsgen (Germany), Jalid Sehouli (Germany) | ||
| 167-25 | Prognostic Role of Expression of Il-1 a, Il-1 B, Il-1 Ra and Il-10 in Advanced Epithelial Ovarian Cancer (Oc) Ionela Cristina Pirvulescu (Romania), Elena Ioana Braicu (Romania), Alexadru Mustea (Germany), Dominique Könsgen (Germany), Jalid Sehouli (Germany) | ||
| 167-26 | Polymorphisms in the Il-10 Gene Are Correlated with Levels of Il-10 Protein in Ovarian Cancer(Oc) Elena Ioana Braicu (Romania), Ionela Cristina Pirvulescu (Romania), Alexandru Mustea (Germany), Dominique Könsgen (Germany), Jalid Sehouli (Germany) | ||
| 167-27 | Substituted Heterocyclic Hydroxamic acids as Histone Deacetylase inhibitors Akella SSV Srinivas (India), Virendra Kachhadia (India), Kaveri Balan (India), K Mathiyazhagan (India), L. Manikandan (India), R. Velmurgan (India), S. Thara (India), Sri Ram Rajagopal (India), Uma Ramachandran (India), G. Om Reddy (India) | ||
| 167-28 | Impact of Nutritional Status on Treatment Toxicity in Concomitant Chemoradiation: an Indian Experience Subrata Saha (India), Aloke GhosDastidar (India) | ||
| 167-29 | Osmotic Fragility Test of Red Cell for Cancer Patients wenjian Sun (China) | ||
| 167-30 | Challenges Toresearch and Management of Prostate Cancer in a Developing Economy: a Call for International Cooperation ADEMOLA A. POPOOLA (Nigeria), SULYMAN KURANGA (Nigeria) | ||
| 167-31 | Establishment of highly metastatic murine breast cancer cell line to bone marrow Tomoko Okada (Japan), Masato Kodaka (Japan) | ||
| 167-32 | Resveratrol-Cu(II) Induced DNA Breakage in Human Peripheral Lymphocytes: Implications for a Putative Mechanism for Anticancer Properties of Plant Polyphenols SM Hadi (India) | ||
| 167-33 | Promoter hypermethylation of genes in p53 pathway is the frequent event in liver fluke related cholangiocarcinoma Temduang Limpaiboon (Thailand), Preeda Prakrankamanant (Thailand), Nutnaree Kamgate (Thailand), Patimaporn Chaopatchayakul (Thailand), Inthira Tussakhon (Thailand), Prasong Khaenam (Thailand), Patcharee Jearanaikoon (Thailand), Banchob Sripa, Vajarabhongsa Bhudhisawasdi | ||
| 167-34 | Over-Expression of P27kip1 Threonine Residue 187 Mutant Type Gene Induces G0 Phase Arrest and Enhances Radiosensitivity Induced by 60 Co Gamma -Irradiation in Hepatocellular Carcinoma Hepg2 Cell Line Xiaoxiang Guan (China), Longbang Chen (China), Jinghua Wang (China), Huaicheng Geng (China), Xiaoyuan Zhu (China), Qun Zhang (China) | ||
| 167-35 | Gene expression analysis of osteosarcoma cell lines following caffeine potentiated chemotherapy using cDNA macroarray Sadao Ii (Japan) | ||
| 167-36 | Metabolic Characterisation by in Vivo Proton Magnetic Resonance Spectroscopy(Pmrs)-Tailors the Management of the Soft Tissue Sarcomas? Madhabananda Kar (India), S.V.S Deo (India), N.K. Shukla (India), N.R. Jagannathan (India), Uma Sharma (India), Sidharth DattaGupta (India), Sanjay Thulkar (India) | ||
| 167-37 | Identification and functional study of a peptide which mimics MUC1 sialylated carbohydrate epitope Lixin Zhang (China), Jinyong Pan (China), Chunhai Li (China) | ||
| 167-38 | Impaired MHC Class I antigen surface expression demonstrated as the major event for loss of immune surveillance in cervical cancer is unlikely due to down regulation of heavy chain and B 2M expression Patcharee Jearanaikoon (Thailand), Temduang Limpaiboon (Thailand), Surasak Wanrum (Thailand), Chanvit Leelayuwat (Thailand), Anucha Puapairoj (Thailand) | ||
| 167-39 | Expression and Clinical Significance of Estrogen Receptor-Related Receptor Isoforms in Endometrial Carcinoma Tissues Min Gao (China), Lihui Wei (China), Pengming Sun (China) | ||
| 167-40 | Translating research into communication into improved clinical practice in cancer genetics Claire Foster* (United Kingdom), Rosalind Eeles, Audrey Ardern-Jones (United Kingdom), Sue Davolls (United Kingdom), Clare Moynihan (United Kingdom), Maggie Watson (United Kingdom) | ||
| 167-41 | Identification of Novel Alternate Spliced Variant of Human Sin3 in Oral Carcinoma Cell Lines Daman Saluja (India), Masook Ali (India), Harish Batra (India), Vineet Kumar (India), Nidhi Bansal (India), Leena Wig (India) | ||
| 167-42 | Characterization of Telomerase-Immortalized Primary Non-Malignant and Malignant Tumor-Derived Human Prostate Epithelial Cell Cultures Yongpeng Gu (USA), Hongzhen Li (USA), Jun Miki (USA), Kee-Hong Kim (USA), Bungo Furusato (USA), Isabell Sesterhenn (USA), Wei-Sing Chu (USA), David G. McLeod, Charles M. Ewing (USA), Shiv Srivastava (USA), John B. Isaacs (USA), Johng S. Rhim (USA) | ||
| 167-43 | Over-Expression of Estrogen Receptor-Related Receptor Alpha in Endometrial Carcinoma Cells May Provide an Er-Independent Mechanism to Resist the Endocrine Therapy Pengming Sun (China), Lihui Wei (China), Min Gao (China), Jiangliu Wang (China), Alexander Mustea (Germany), Jalid Sehouli (Germany) | ||
| 167-44 | Lactotransferrin: a Frequent Expression down-Regulation in Prostate Cancer Syed Shaheduzzaman (USA), Lionel L. Banez (USA), Anu Vishwanath (USA), Bungo Furusato (USA), Martin Nau (USA), Lakshmi Ravindranath (USA), Yidong Chen (USA), Yongmei Chen (USA), Jennifer Cullen (USA), Isabell A. Sesterhenn (USA), Maryanne T. Vahey (USA), David G. McLeod, Gyorgy Petrovics (USA), Vasantha Srikantan (USA), Shiv Srivastava (USA) | ||
| 167-45 | Incidence of Fusion Gene Transcripts E2a-Pbx, Tel-Aml, Mbcr-Abl and Mll-Af4 in South Indian Acute Lymphoblastic Lleukemias KarunakaranNancy Nirmala (India), Sudhakar natarajan (India), Rajalekshmy raghavan kamalalyam (India), Ramanan Ganapati (India), Rajkumar Thangarajan (India) | ||
| 167-46 | The Gastrin Releasing Peptide Receptor (BB2r) as a Potential Target for Diagnostic and Therapeutic Radiopharmaceuticals Timothy J. Hoffman (USA), T. L. Rold (USA), S. Daibes Figueroa (USA), G. L. Sieckman (USA), J.C. Garrison (USA), C.T. Winkelmann, C. J. Smith (USA), W.A. Volkert (USA) | ||
| 167-47 | Bcl6 Mutation Profile in Non Hodgkins Lymphoma Nirmala Nancy Karunakaran (India), SASIKALA SACHITHANANDAN (India), URMILA MAJHI (India), SHIRELY SUNDARSINGH (India), RAJKUMAR THANGARAJAN (India) | ||
| 167-48 | Characteristics of the Antibody Erithrocytes Diagnosticum for Definition of Cea Sarimbek N. Navruzov . (Uzbekistan) | ||
| 167-49 | Cancer Prevention and Control Program in China Youlin Qiao (China) | ||
| 167-50 | Secondary Chromosome Abnormalities in ETV6/RUNX1 Fusion Positive Childhood Acute Lymphoblastic Leukemia (ALL) Surabhi Kakati (USA), AnneMarie W. Block (USA), Sheila N.J. Sait (USA), Barbara J. Bambach (USA), Loma Fitzpatrick (USA), Mauro Grossi (USA), Maryjane Petruzzi (USA), Martin Brecher (USA) | ||
| 167-51 | Sheth F.J F.J. SHETH (India), M DESAI (India), J.S. VIN (India), J.J. SHETH (India) | ||
| 167-52 | Prostate Cancer Associated Androgen Receptor Mutation Promotes Cell Growth and Abrogates P53 Mediated Apoptosis Chen Sun (USA), Albert Dobi (USA), David G. McLeod, Shiv Srivastava (USA) | ||
| 167-53 | Pgp, Cd34 and Tumor Grad in Squamous Cell Carcinoma of the Head and Neck Mohammed abd elmotaal Gomaa II (Egypt) | ||
| 167-54 | ETS-Related Gene (ERG), a Frequent Proto-Oncogene Expression Alteration in Prostate Cancer with Potentials in Diagnosis and Prognosis Syed Shaheduzzaman (USA), Gyorgy Petrovics (USA), Vasantha Srikantan (USA), Bungo Furusato (USA), Isabell A. Sesterhenn (USA), David G. McLeod (USA), Shiv Srivastava (USA) | ||
| 167-55 | P53 and Bcl2 in Cancer Larynx Mohammed abd elmotaal Gomaa (Egypt) | ||
| 167-56 | Molecular Imaging in Tumor Targeted Radiopharmaceutical Drug Development Timothy J. Hoffman (USA), S. Daibes Figueroa (USA), T. L. Rold (USA), G. L. Sieckman (USA), C.T. Winkelmann (USA), L. Ma (USA), W.A. Volkert (USA) | ||
| 167-57 | Epigenetic Inactivation Is a Preferential Mechanism for Silencing Riz1 in Cholangiocarcinoma Prasong Khaenam (Thailand), Temduang Limpaiboon, Patcharee Jearanaikoon, Banchob Sripa, Chawalit Pairojkul, Vajarabhongsa Bhudhisawasdi | ||
| 167-58 | Molecular stratification of metastatic potential in colorectal cancer Ichiro Takemasa (Japan), Masataka Ikeda (Japan), Takamichi Komori (Japan), Shinichi Yoshioka (Japan), Makoto Yamasaki (Japan), Masaaki Motoori (Japan), Hirofumi Yamamoto (Japan), Mitsugu Sekimoto (Japan), Kenichi Matsubara (Japan), Morito Monden (Japan) | ||
| 167-59 | Indian National Training Project (Intp) in Practical Pediatric Oncology Purna A. Kurkure (India), Bharat A. Agarwal (India), Anupam Sachdeva (India), Ram Marwaha (India), Rashmi Dalvi (India), Archana Kumar (India), Laxman S. Arya (India), V. Choudhary (India), Sverre O. Lie (Norway) | ||
| 167-60 | Determining the Need for Cancer Centers of Excellence IRENE CHRISTODOULOU (Greece), EFTHIMIOS PAPAMICHAEL (Greece), CHRIS POGONIDIS (Greece), EUGENIA XENODOXIDOU (Greece) | ||
| 167-61 | Radiolabelled Microsperic Biodegradable Therapeutics:Studies with U87 Mg Glioma Cell Lines JAYA SHUKLA (India), GURU PAD BANDOPADHYAYA (India) | ||
| 167-62 | Association of Functionally Important Polymorphisms of Tobacco Responsive Cytochrome P450 and Glutathione- S- Transferases with Head and Neck Cancer Mohan Chandra Pant (India), Parag P. Shah (India), Arvind P. Singh (India), Madhu Singh (India), Rakesh Kumar Gupta (India), Rahat Hadi (India), Devendra Parmar (India) | ||
| 167-63 | Physician and Registrar Staging Audit: How did they do? Darlene J. Dale (Canada), James Duncan Brierley (Canada), Alexandra Easson (Canada), Dawn Gilmour (Canada), Vitkas Gupta (Canada), Monika Krzyzanowska (Canada), Tony Panzarella (Canada), Michael Thompson (Canada), Gregory Zufelt (Canada) | ||
| 167-64 | Advocacy for Cancer Control: the Role of a Comprehensive Cancer Centre in a Developing Country Ketayun Dinshaw (India) | ||
| 167-65 | Cancer Research: Status and Priorities at the Tata Memorial Centre, Mumbai Ketayun Dinshaw (India) | ||
| 167-66 | Cantelmed - Tata Memorial Centre Cancer Telemedicine Service Ketayun Dinshaw (India), Dr.(Mrs) Rekha R. Batura (India) | ||
| 167-67 | Establishing The First Tumour Tissue Repository (TTR) In India Roshni F. Chinoy (India), Katy A. Dinshaw (India) | ||
| 167-68 | Inhibitors of the cyclooxygenase-2 and 5-lipoxygenase pathways have superadditive effects on inducing apoptosis and reducing cell growth in human colon cancer Federico Perna (Italy), Giuliano Perigli (Italy), Manuela Masini, Sergio Capaccioli (Italy), Nicola Schiavone (Italy), Matteo Lulli (Italy), Andrea Lapucci (Italy), Fabio Cianchi (Italy) | ||
| 167-69 | From Policy to Practice: Assessing the Impact of Staging Policies for Recording Cancer Stage across Canada David Wiljer (Canada), James Brierley (Canada), Heather Logan | ||
| 167-70 | From Confusion to Clarity: Expediting Care and Improving Outcomes through Collaboration Sarah R. Wilson (USA), Richard B. Reiling (USA), Barbara LiPira (USA), Patricia Nebus (USA) | ||
| 167-71 | Allele Loss on Chromosome 11p15 in Epithelial Ovarian Tumors Igor V. Panichenko (Russia), Irina B. Zborovskaya (Russia), Vladimir N. Bogatyrev (Russia), Kirill I. Zhordania (Russia) | ||
| 167-72 | Challenges In Building A Cancer Clinical Trials (CCT) Database For Michigan Nancy McCrohan (USA), E. Sue Haviland (USA), Mary Malloy (USA), Mary Ann Gregor (USA), Debra D. Kimball (USA) | ||
| 167-73 | Estimates of Medical Costs Attributable to Cancer in the U.S Florence Tangka (USA), Eric A. Finkelstein (USA), Ian C. Fiebelkorn (USA), Donatus Ekwueme (USA), Gayle Clutter (USA) | ||
| 167-74 | Study on the methods to test average diameter of tube-like structure in 3D status based on the 2D random sections and principle of stereology Hong Shen (China) | ||
| 167-75 | Cancer Registrars Workforce Study: Critical Issues for Frontline Workers in Cancer Data Collection and Management Susan A. Chapman (USA), Linda Mulvihill (USA) | ||
| 167-76 | Is training in laparoscopic resection for cancer a necessity in a country with limited resources? Ayyappan Srinivasan (India) | ||
| 167-77 | TEL-AML 1 gene fusion in Acute lymphoblastic leakemia involving chromosomal translocation t(12;21) and its correlation with clinical ,morphological, haematological and immunophenotype findings Susheela Mungamuru (India) | ||
| 167-78 | Is General Surgery Dying? Career Choice of Interns and Relationship to Surgical Oncology Residency Taiwo A. Lawal (Nigeria) | ||
| 167-79 | Implementing data management programs in low-income countries: Lessons from Honduras Scott Howard (USA), Lisa Ayoub (USA), Ligia Fu (Honduras), Armando Pena (Honduras), Monika Metzger (USA), Judith Wilimas (USA), Ching-Hon Pui (USA), Ronald Barr (Canada), Raul Ribeiro (USA) | ||
| 167-80 | Supporting Communities of Practice Barbara Poole (Canada), Martina Strack (Canada), Rona Cheifetz (Canada), Gail Compton (Canada), Andrew Murray (Canada) | ||
| 167-81 | Effect of Chemotherapy on Lipid Peroxidation in Leukemia FARHAD NEHMATULLA Hussen III (Iraq) | ||
| 167-82 | The ACTION Project: Accelerating Cancer Trials through an Internet-based Collaborative Community in Ontario Doina Lupea (Canada), Galina Kovacik (Canada), James R. Wright (Canada), Alejandro (Alex) Jadad (Canada) | ||
See more of Cancer Research, Detection and Treatment
See more of The UICC World Cancer Congress 2006